Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 338.35 million compared to CNY 275.53 million a year ago. Revenue was CNY 338.35 million compared to CNY 275.53 million a year ago.

Net income was CNY 29.71 million compared to CNY 64.45 million a year ago. Basic earnings per share from continuing operations was CNY 0.045 compared to CNY 0.0977 a year ago. Diluted earnings per share from continuing operations was CNY 0.045 compared to CNY 0.0977 a year ago.